Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalamine for Prevention of Diverticulitis Flares
NCT01120340Phase 3Completed
- Sponsor
- SOFAR
- Start
- Oct 2005
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Salcrozine in diverticulitis, sponsored by SOFAR. Started Oct 2005; status: completed.
02
Drugs
Salcrozine
03
Conditions
diverticulitis
Beyond the preview
Go deeper on NCT01120340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01120340.